These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11367895)

  • 21. Radiation Therapy Oncology Group. Research Plan 2002-2006. Lung Cancer Committee.
    Bynhardt R; Komaki R; Ettinger D; Johnstone D; Bradley J; Franko A; Gaspar L; Gillin M; Langer C; Layne E; Movsas B; Munden R; Sause W; Stern J; Hsu J; Hartsell W; Yesner R;
    Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):44-52. PubMed ID: 11641014
    [No Abstract]   [Full Text] [Related]  

  • 22. Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program.
    Okunieff P; Hammond E; Grignon D; Langer C; Pajak TF; Ang K; Bruner DW; Travis E; Greven K; Guha A; Moulder J; Pollack A; Scarantino C; Sneige N; Watson J; Amin M; Bondy M; Chakravarti A; Chapman JD; Dicker A; Harris J; Koch W; Komaki R; Lange C; McBride W; Mitchell J; Milas L; Movsas B; Pandya K; Pienta K; Regine W; Ritter M; Rubin P; Safran H; Sauter E; Schell M; Stevens C; Trotti A; Vikram B;
    Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):75-87. PubMed ID: 11641020
    [No Abstract]   [Full Text] [Related]  

  • 23. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
    Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The actions of the French Society of Radiation Oncology (SFRO), within the frame of Plan cancer and the recent events of radioprotection].
    Bolla M; Mazeron JJ; Mornex F; Eschwège F
    Cancer Radiother; 2007 Nov; 11(6-7):305-8. PubMed ID: 17884664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in practice of breast cancer radiotherapy 1998-2002: an Australasian survey.
    Drummond R; Power A; Evans A; Luxford K; Blakey D; Delaney G; Rodger A
    Australas Radiol; 2005 Feb; 49(1):44-52. PubMed ID: 15727609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee.
    Eisenburg BL; Alektiar K; Ballo M; DeLaney TF; Ettinger D; Harmon D; Harris J; Joyce M; Kraybill WG; Leider S; Lucas D; Peterson I; Pollock RE; Pritchard D; Schwartz HS; Yasko AW; Pisters PT; Patel SR; watson J;
    Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):53-5. PubMed ID: 11641015
    [No Abstract]   [Full Text] [Related]  

  • 28. A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading.
    Khalid U; McGough C; Hackett C; Blake P; Harrington KJ; Khoo VS; Tait D; Norman AR; Andreyev HJ
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1432-41. PubMed ID: 16580497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of bladder cancer trials in the Radiation Therapy Oncology Group.
    Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM;
    Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intervention to improve psychological functioning for newly diagnosed patients with cancer.
    Rawl SM; Given BA; Given CW; Champion VL; Kozachik SL; Kozachik SL; Barton D; Emsley CL; Williams SD
    Oncol Nurs Forum; 2002 Jul; 29(6):967-75. PubMed ID: 12096294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.
    Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp L; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Hart AA; Nowak PJ; van Herk M; Rasch CR
    Radiother Oncol; 2005 Nov; 77(2):182-90. PubMed ID: 16256231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computerized symptom and quality-of-life assessment for patients with cancer part II: acceptability and usability.
    Mullen KH; Berry DL; Zierler BK
    Oncol Nurs Forum; 2004 Sep; 31(5):E84-9. PubMed ID: 15378105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiomodifiers and the progress of radiation oncology].
    Iarmonenko SP
    Vopr Onkol; 1995; 41(2):93-4. PubMed ID: 7483456
    [No Abstract]   [Full Text] [Related]  

  • 35. A historical perspective of the radiation oncology workforce and ongoing initiatives to impact recruitment and retention.
    Kresl JJ; Drummond RL
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):8-14. PubMed ID: 15337534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do we need to improve pain management in the radiation oncology department?
    Janjan N
    Nat Clin Pract Oncol; 2005 Mar; 2(3):130-1. PubMed ID: 16264903
    [No Abstract]   [Full Text] [Related]  

  • 37. The future of radiation oncology: the evolution, diversification, and survival of the specialty.
    Zietman A
    Semin Radiat Oncol; 2008 Jul; 18(3):207-13. PubMed ID: 18513631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First author research productivity of United States radiation oncology residents: 2002-2007.
    Morgan PB; Sopka DM; Kathpal M; Haynes JC; Lally BE; Li L
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1567-72. PubMed ID: 19131182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical Oncology Dispensary, Chelyabinsk--the clinical branch of the Russian Center for Radiology Research in the Urals Region].
    Vazhenin AV; Domozhirova AS; Vazhenina DA; Kaplunovich AP; Zhuravl'ëv EA
    Vopr Onkol; 2009; 55(4):483-5. PubMed ID: 19947377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.